rubi gaba Search Results


rubi gaba trimethylphosphine  (TargetMol)
N/A
   Buy from Supplier
rubi gaba  (Tocris)
93
Tocris rubi gaba
Rubi Gaba, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rubi+gaba/RuBi-GABA/bio_rxiv__2020__06__08__139592-222-0-6
Average 93 stars, based on 1 article reviews
rubi gaba - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
rubi gaba trimethylphosphine  (Tocris)
94
Tocris rubi gaba trimethylphosphine
Rubi Gaba Trimethylphosphine, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rubi+gaba/RuBi+GABA+trimethylphosphine/10__1113_slash_jp279221-116-1-7
Average 94 stars, based on 1 article reviews
rubi gaba trimethylphosphine - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
rubigaba  (Tocris)
93
Tocris rubigaba
Presynaptic locus of change resulting in enhanced iSPN-ChI GABA signaling. (A) Sample traces showing two 0.5 ms long 470 nm light pulses 50 ms apart (20 Hz) and the resulting inward currents in WT (black) and zQ175 +/− (red) ChIs. (B) Box plots showing medians of the PPR in ChIs from WT and zQ175 +/− mice. PPR is defined as peak amplitude of 2nd eIPSC/peak amplitude of the 1st eIPSC. (C) Application of the D2 receptor agonist quinpirole (1 μM) causes a decrease in eIPSC amplitude at the iSPN-ChI synapse in both WT and zQ175 +/− mice. (D) Strontium-evoked asynchronous GABA release amplitude is unchanged in zQ175 +/− mice. Replacement of calcium with strontium results in asynchronous neurotransmitter release. Sample traces of optogenetically evoked events in ChIs taken from WT and zQ175 +/− mice. Events smaller than 5x RMS of the noise were eliminated from analysis. (E) Box plots showing median amplitude and frequency of evoked asynchronous IPSCs for WT and zQ175 +/− mice. (F) GABA current elicited at ChIs from <t>RuBiGABA</t> uncaging. Box plots showing medians of GABAA receptor currents following uncaging. * P < 0.05.
Rubigaba, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rubi+gaba/RuBi-GABA/pmc07854471-86-21-24
Average 93 stars, based on 1 article reviews
rubigaba - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
rubi-gaba  (Aladdin Scientific Corporation)
N/A
Store at -20°C. It is important to note that this product is reported to be light sensitive. Store In the Dark. Store under desiccating conditions.
   Buy from Supplier
rubi-gaba  (Biosynth Carbosynth)
N/A
   Buy from Supplier
rubi-gaba  (BOC Sciences)
N/A
RuBi-GABA, a ruthenium-bipyridine-triphenylphosphine caged GABA, is a photolabile protecting group used for highly efficient visible light GABA uncaging.
   Buy from Supplier
rubi-gaba  (TargetMol)
N/A
   Buy from Supplier

Image Search Results


Presynaptic locus of change resulting in enhanced iSPN-ChI GABA signaling. (A) Sample traces showing two 0.5 ms long 470 nm light pulses 50 ms apart (20 Hz) and the resulting inward currents in WT (black) and zQ175 +/− (red) ChIs. (B) Box plots showing medians of the PPR in ChIs from WT and zQ175 +/− mice. PPR is defined as peak amplitude of 2nd eIPSC/peak amplitude of the 1st eIPSC. (C) Application of the D2 receptor agonist quinpirole (1 μM) causes a decrease in eIPSC amplitude at the iSPN-ChI synapse in both WT and zQ175 +/− mice. (D) Strontium-evoked asynchronous GABA release amplitude is unchanged in zQ175 +/− mice. Replacement of calcium with strontium results in asynchronous neurotransmitter release. Sample traces of optogenetically evoked events in ChIs taken from WT and zQ175 +/− mice. Events smaller than 5x RMS of the noise were eliminated from analysis. (E) Box plots showing median amplitude and frequency of evoked asynchronous IPSCs for WT and zQ175 +/− mice. (F) GABA current elicited at ChIs from RuBiGABA uncaging. Box plots showing medians of GABAA receptor currents following uncaging. * P < 0.05.

Journal: Frontiers in Systems Neuroscience

Article Title: Enhanced GABAergic Inhibition of Cholinergic Interneurons in the zQ175 +/− Mouse Model of Huntington's Disease

doi: 10.3389/fnsys.2020.626412

Figure Lengend Snippet: Presynaptic locus of change resulting in enhanced iSPN-ChI GABA signaling. (A) Sample traces showing two 0.5 ms long 470 nm light pulses 50 ms apart (20 Hz) and the resulting inward currents in WT (black) and zQ175 +/− (red) ChIs. (B) Box plots showing medians of the PPR in ChIs from WT and zQ175 +/− mice. PPR is defined as peak amplitude of 2nd eIPSC/peak amplitude of the 1st eIPSC. (C) Application of the D2 receptor agonist quinpirole (1 μM) causes a decrease in eIPSC amplitude at the iSPN-ChI synapse in both WT and zQ175 +/− mice. (D) Strontium-evoked asynchronous GABA release amplitude is unchanged in zQ175 +/− mice. Replacement of calcium with strontium results in asynchronous neurotransmitter release. Sample traces of optogenetically evoked events in ChIs taken from WT and zQ175 +/− mice. Events smaller than 5x RMS of the noise were eliminated from analysis. (E) Box plots showing median amplitude and frequency of evoked asynchronous IPSCs for WT and zQ175 +/− mice. (F) GABA current elicited at ChIs from RuBiGABA uncaging. Box plots showing medians of GABAA receptor currents following uncaging. * P < 0.05.

Article Snippet: 6,7-dinitroquinoxaline-2,3-dione (DNQX) 10 μM, (2R)-amino-5-phosphonovaleric acid (APV) 50 μM (HelloBio), SR95531 hydrobromide (Gabazine) 10 μM (Tocris), Quinpirole 1 μM (Tocris), and RuBiGABA 10 μM (Tocris) were bath applied for at least 5 min before recording.

Techniques: